Quantitative and qualitative liver CT: imaging feature association with histopathologically confirmed hepatic cirrhosis
- PMID: 35583820
- DOI: 10.1007/s00261-022-03550-0
Quantitative and qualitative liver CT: imaging feature association with histopathologically confirmed hepatic cirrhosis
Abstract
Purpose: To assess the diagnostic performance of quantitative and qualitative imaging features of hepatic cirrhosis on CT.
Methods: A single-center retrospective cohort study was performed on all patients who had undergone non-targeted liver biopsy < 3 months following abdominal CT imaging between 2007 and 2020. Histopathology was required as a reference standard for hepatic cirrhosis diagnosis. Two readers independently assessed all CT quantitative and qualitative features, blinded to the clinical history and the reference standard. The diagnostic performance of each imaging feature was assessed using multivariate regression and logistic regression in a recursive feature elimination framework.
Results: 98 consecutive patients met inclusion criteria including 26 with histopathologically confirmed hepatic cirrhosis, and 72 without cirrhosis. Liver surface nodularity (p < 0.0001), lobar redistribution (p < 0.0001), and expanded gallbladder fossa (p < 0.0016) were qualitative CT features associated with liver cirrhosis consistent between both reviewers. Liver surface nodularity demonstrated highest sensitivity (73-77%) and specificity (79-82%). Falciform space width was the only quantitative feature associated with cirrhosis, for a single reviewer (p < 0.04). Using a recursive feature elimination framework, liver surface nodularity and falciform space width were the strongest performing features for identifying cirrhosis. No feature combinations strengthened diagnostic performance.
Conclusion: Many quantitative and qualitative CT imaging signs of hepatic cirrhosis have either poor accuracy or poor inter-observer agreement. Qualitative imaging features of hepatic cirrhosis on CT performed better than quantitative metrics, with liver surface nodularity the most optimal feature for diagnosing hepatic cirrhosis.
Keywords: Cirrhosis; Computed tomography; Liver; Qualitative evaluation; Quantitative evaluation.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Imaging Biomarkers of Hepatic Fibrosis: Reliability and Accuracy of Hepatic Periportal Space Widening and Other Morphologic Features on MRI.AJR Am J Roentgenol. 2021 May;216(5):1229-1239. doi: 10.2214/AJR.20.23099. Epub 2021 Mar 17. AJR Am J Roentgenol. 2021. PMID: 33729883 Free PMC article.
-
Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis.AJR Am J Roentgenol. 2016 Dec;207(6):1194-1199. doi: 10.2214/AJR.16.16514. Epub 2016 Aug 30. AJR Am J Roentgenol. 2016. PMID: 27575867
-
Noninvasive diagnosis of liver cirrhosis: qualitative and quantitative imaging biomarkers.Abdom Radiol (NY). 2024 Jun;49(6):2098-2115. doi: 10.1007/s00261-024-04225-8. Epub 2024 Feb 19. Abdom Radiol (NY). 2024. PMID: 38372765 Review.
-
Liver Surface Nodularity Score Allows Prediction of Cirrhosis Decompensation and Death.Radiology. 2017 Jun;283(3):711-722. doi: 10.1148/radiol.2016160799. Epub 2016 Nov 3. Radiology. 2017. PMID: 27809664
-
Diagnostic performance of liver fibrosis assessment by quantification of liver surface nodularity on computed tomography and magnetic resonance imaging: systematic review and meta-analysis.Eur Radiol. 2022 May;32(5):3377-3387. doi: 10.1007/s00330-021-08436-1. Epub 2022 Jan 19. Eur Radiol. 2022. PMID: 35043290
Cited by
-
Assessment of high-risk gastroesophageal varices in cirrhotic patients using quantitative parameters from dual-source dual-energy CT.Abdom Radiol (NY). 2025 Jul;50(7):2783-2793. doi: 10.1007/s00261-024-04666-1. Epub 2024 Nov 15. Abdom Radiol (NY). 2025. PMID: 39542947
-
The Protective Role of Baicalin in the Regulation of NLRP3 Inflammasome in Different Diseases.Cell Biochem Biophys. 2025 Jun;83(2):1387-1397. doi: 10.1007/s12013-024-01597-y. Epub 2024 Oct 23. Cell Biochem Biophys. 2025. PMID: 39443419 Review.
-
Hepatobiliary scintigraphy and liver function changes in patients with hepatocellular carcinoma treated with 166Ho-radioembolization : HBS in HCC treated with holmium-166.EJNMMI Res. 2025 Jan 9;15(1):2. doi: 10.1186/s13550-025-01196-9. EJNMMI Res. 2025. PMID: 39786516 Free PMC article.
-
Deep Learning for Computed Tomography Assessment of Hepatic Fibrosis and Cirrhosis: A Systematic Review.Mayo Clin Proc Digit Health. 2023 Oct 27;1(4):574-585. doi: 10.1016/j.mcpdig.2023.08.008. eCollection 2023 Dec. Mayo Clin Proc Digit Health. 2023. PMID: 40206310 Free PMC article. Review.
References
-
- Garcia-Tsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology. 2010;51(4):1445–9. https://doi.org/ https://doi.org/10.1002/hep.23478 - DOI - PubMed
-
- Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383(9930):1749–61. https://doi.org/ https://doi.org/10.1016/S0140-6736(14)60121-5 - DOI - PubMed
-
- Statistics Canada. Table 13-10-0801-01. Leading ca uses of death, total population (age standardization using 2011 population). https://doi.org/10.25318/1310080101-eng
-
- Heron M. National Vital Statistics Reports Deaths: leading causes for 2017. Natl Vital Stat Rep. 2019;68(6):1–77. - PubMed
-
- Flemming JA, Djerboua M, Booth CM TN. Increasing burden of cirrhosis projected to 2040 in Canada: implications for prevention, screening, and management. Int Liver Congr. 2020;73:S45.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous